5 days ago
ACAD
AnalystsSumant KulkarniSumant Kulkarni's Stock Forecasts
AnalystsSumant Kulkarni
Analyst Ranking
Top 17%
#889 out of 5314 analysts
Average Return
+7.5%
Win Rate
49%63 out of 128
Risk vs Reward
Poor
Good
Sumant Kulkarni's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cervomed IncCRVO | +344.62% | $1.95 | $8.67 | 2024-12-11 - 2025-12-10 | Strong Buy |
Definium Therapeutics IncDFTX | +277.69% | $11.70 | $44.19 | 2025-11-07 - 2026-07-02 | Strong Buy |
Compass Pathways PLCCMPS | +213.82% | $4.34 | $13.62 | 2025-08-01 - 2026-07-02 | Strong Buy |
Sage Therapeutics IncSAGE | +157.05% | $30.01 | $77.14 | 2020-04-08 - 2021-04-08 | Strong Buy |
Compass Pathways PLCCMPS | +141.49% | $5.64 | $13.62 | 2026-03-26 - 2026-07-02 | Strong Buy |
Sumant Kulkarni Analyst Color
Get additional color on Sumant Kulkarni's coverage of popular stocks
8 days ago
CMPS
a year ago
CRVO
3 years ago
HELP
3 years ago
SAGE
3 years ago
HELP
Sumant Kulkarni's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cybin IncHELP | 10 | Strong Buy | $42.00 | +573.08% | Maintains | 3 days ago |
Definium Therapeutics IncDFTX | 5 | Strong Buy | $58.00 | +31.25% | Maintains | 4 days ago |
Acadia Pharmaceuticals IncACAD | 12 | Strong Buy | $36.00 | +38.62% | Maintains | 5 days ago |
Compass Pathways PLCCMPS | 7 | Strong Buy | $20.00 | +46.84% | Maintains | 8 days ago |
Zevra Therapeutics IncZVRA | 10 | Strong Buy | $29.00 | +107.44% | Maintains | 23 days ago |
Ataibeckley IncATAI | 5 | Strong Buy | $15.00 | +189.02% | Maintains | 2 months ago |
Annovis Bio IncANVS | 5 | Strong Buy | $17.00 | +780.83% | Maintains | 3 months ago |
Neurocrine Biosciences IncNBIX | 12 | Strong Buy | $200.00 | +14.77% | Maintains | 3 months ago |
Biogen IncBIIB | 14 | Strong Buy | $245.00 | +13.36% | Maintains | 3 months ago |
Stoke Therapeutics IncSTOK | 6 | Strong Buy | $60.00 | +83.49% | Maintains | 3 months ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $35.00 | -5.63% | Initiates Coverage On | 3 months ago |
Clene IncCLNN | 7 | Strong Buy | $48.00 | +686.89% | Maintains | 4 months ago |
Gh Research PLCGHRS | 5 | Strong Buy | $39.00 | +44.39% | Maintains | 6 months ago |
Cervomed IncCRVO | 6 | Strong Buy | $27.00 | +660.56% | Maintains | a year ago |
Sage Therapeutics IncSAGE | 7 | Hold | $8.50 | N/A | Maintains | a year ago |
Voyager Therapeutics IncVYGR | 4 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $132.00 | N/A | Downgrades | a year ago |
Bioxcel Therapeutics IncBTAI | 7 | Strong Buy | $80.00 | N/A | Maintains | a year ago |
Tvardi Therapeutics IncTVRD | 4 | Hold | $12.00 | N/A | Downgrades | 2 years ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Hold | $1.11 | N/A | Downgrades | 3 years ago |
Quince Therapeutics IncQNCX | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 3 | Strong Buy | $150.00 | N/A | Maintains | 5 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Strong Buy | $20.00 | N/A | Maintains | 7 years ago |
Avexis IncAVXS | 1 | Hold | $120.00 | N/A | Maintains | 8 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.